Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418652![]() (4-{[4-({3- [methyl(methylsulfonyl)amino]benzyl} am...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.380 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418605![]() (3-methoxy-4-({4-[({6-methyl-2- [methyl(methylsulfo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418597![]() (US10450297, Example 40 | methyl 4-({4-[({2- [methy...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418659![]() (4-{[4-({2-methyl-6- [methyl(methylsulfonyl)amino]b...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418656![]() (N-[3-({[2-{[4-(aminomethyl)phenyl]amino}- 5-(trifl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418655![]() (N-methyl-4-({4-[({6-methyl-4- [methyl(methylsulfon...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418653![]() (N-methyl-4-{[4-({3- [methyl(methylsulfonyl)amino]b...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418651![]() (US10450297, Example 98 | ethyl [4-({4-[({2- [methy...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418650![]() (N-ethyl-4-({4-[({3- [methyl(methylsulfonyl)amino]p...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418649![]() (N-methyl-4-{[4-({2- [methyl(methylsulfonyl)amino]b...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418634![]() (N-[5-({[2-anilino-5- (trifluoromethyl)pyrimidin-4-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418624![]() (N-[2-(([2-anilino-5- (trifluoromethyl)pyrimidin-4-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418610![]() (N-methyl-4-({4-[({6-methyl-2- [methyl(methylsulfon...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418609![]() (N-methyl-4-({4-[({2- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418607![]() (N-[3-({[2-anilino-5- (trifluoromethyl)pyrimidin-4-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418606![]() (N-[3-({[2-anilino-5- (trifluoromethyl)pyrimidin-4-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418604![]() (3-methoxy-4-({4-[({2- [methyl(methylsuffonyl)amino...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418603![]() (3-methoxy-4-{[4-{[3- (methylsulfonyl)benzyl]amino}...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418856![]() (N-[2-({[2-({4-[(1S)-1- aminoethyl]phenyl}amino)-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.593 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418853![]() (N-[3-({[2-({4-[(1R)-1- aminoethyl]phenyl}amino)-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418854![]() (N-[3-({[2-({4-[(1R)-1- aminoethyl]phenyl}amino)-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418851![]() (N-[3-({[2-({4-[(1R)-1- aminoethyl]phenyl}amino)-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418858![]() (2-chloro-4-({4-[({2- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418859![]() (2-chloro-4-({4-[({3- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418860![]() (2-chloro-4-({4-[({3- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418862![]() (N-[2-({[2-({4-[(1R)-1- aminoethyl]phenyl}amino)-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418862![]() (N-[2-({[2-({4-[(1R)-1- aminoethyl]phenyl}amino)-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418866![]() (N-[3-({4-[({2- [methyl(methylsulfonyl)amino]pyridi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418868![]() (3-fluoro-N-methyl-4-({4-[({3- [methyl(methylsulfon...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418883![]() (N-{3-[({2-[(4-{[(2- hydroxyethyl)amino]methyl}phen...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418884![]() (N-[3-({[2-({4- [(isopropylamino)methyl]phenyl}amin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418888![]() (N-{3-[({2-((4-{[(2- methoxyethyl)amino]methyl}phen...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418889![]() (N-[3-({[2-{[4-({[2-hydroxy-1- (hydroxymethyl)ethyl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418894![]() (2-hydroxy-4-({4-[({2- [methyl(methylsulfonyl)amino...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418902![]() (N,2-dimethyl-4-({4-[({2- [methyl(methylsulfonyl)am...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418907![]() (N'-hydroxy-4-({4-[({2- [methyl(methylsulfonyl)amin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418912![]() (N-[3-({[2-{[4-(1,2- dihydroxyethyl)phenyl]amino}-5...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418913![]() (N-{3-[({2-[(4-{[(2-hydroxy-2- methylpropyl)amino]m...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418914![]() (N-methyl-N-[3-({[2-({4- [(methylamino)methyl]pheny...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418852![]() (N-[2-({[2-({4-[(1R)-1- aminoethyl]phenyl}amino)-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418849![]() (N-methyl-N-[3-({[2-{[4-(morpholin-4- ylmethyl)phen...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418841![]() (3-methyl-4-({4-[({2- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418840![]() (2-methyl-4-{[4-({3- [methyl(methylsulfonyl)amino]b...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418838![]() (2-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418838![]() (2-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418836![]() (2-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418915![]() (N-methyl-N-[2-({[2-({4- [(methylamino)methyl]pheny...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418834![]() (2-methyl-4-({4-[({2- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418834![]() (2-methyl-4-({4-[({2- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Focal adhesion kinase 1 [410-689] (Homo sapiens (Human)) | BDBM418822![]() (3-fluoro-4-({4-[({2- [methyl(methylsulfonyl)amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.595 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare Pharmaceuticals Corporation | Assay Description The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi... | J Med Chem 50: 984-1000 (2007) BindingDB Entry DOI: 10.7270/Q2T72KQP | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 341 total ) | Next | Last >> |